BD Revenue and Competitors
Estimated Revenue & Valuation
- BD's estimated annual revenue is currently $20.3B per year.
- BD's estimated revenue per employee is $371,056
- BD's total funding is $39M.
- BD's current valuation is $74.9B. (January 2022)
Employee Data
- BD has 54574 Employees.
- BD grew their employee count by 4% last year.
BD's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Executive Assistant to President | Reveal Email/Phone |
2 | Executive Assistant to VP | Reveal Email/Phone |
3 | Sales VP - Pharmaceutical Systems BU | Reveal Email/Phone |
4 | Clinical Transformation VP | Reveal Email/Phone |
5 | Area VP Sales | Reveal Email/Phone |
6 | WW VP, Indirect Procurement and Global Process | Reveal Email/Phone |
7 | Clinical Transformation VP | Reveal Email/Phone |
8 | Executive Assistant to VP | Reveal Email/Phone |
9 | WW VP Quality, MMS | Reveal Email/Phone |
10 | WW VP Quality Management, Pharmaceutical Systems | Reveal Email/Phone |
BD Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $7.8M | 31 | 11% | N/A | N/A |
#2 | $12.3M | 49 | -4% | N/A | N/A |
#3 | $15.1M | 60 | 7% | N/A | N/A |
#4 | $8.8M | 35 | -8% | N/A | N/A |
#5 | $3M | 12 | 9% | N/A | N/A |
#6 | $300.4M | 1197 | 3% | N/A | N/A |
#7 | $311.7M | 1242 | 2% | N/A | N/A |
#8 | $0.3M | 1 | -96% | N/A | N/A |
#9 | $8.3M | 33 | 3% | N/A | N/A |
#10 | $13.6M | 54 | 8% | N/A | N/A |
What Is BD?
BD is a medical technology company that serves healthcare institutions, life science researchers, clinical laboratories, industry and the general public. BD manufactures and sells a broad range of medical supplies, devices, laboratory equipment and diagnostic products. For the fiscal year ended September 30, 2002, BD reported total revenues of $4.033 billion.
keywords:Biotechnology
$39M
Total Funding
54574
Number of Employees
$20.3B
Revenue (est)
4%
Employee Growth %
$74.9B
Valuation
N/A
Accelerator
BD News
s new Sustainable Medical Technology Institute is set to be a model of practice within the organization that will bring together BD...
s new Sustainable Medical Technology Institute is set to be a model of practice within the organization that will bring together BD...
FRANKLIN LAKES, N.J., Nov. 4, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced results for the fourth fiscal quarter and full fiscal year ended September 30, 2021. "Our strong performance in fiscal 2021 was driven ...
FRANKLIN LAKES, N.J., Oct. 18, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a new strategy to advance environmental, social and governance (ESG) initiatives, as well as a suite of goals for 2030 and beyond that ...
New product is intended to support biologic drugs with high viscosity formulations*, complex design space requirements and support the delivery of medications for chronic diseases FRANKLIN LAKES, N.J. (October 13, 2021) - BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical ...